ACP Journal Club. In AF, apixaban reduced stroke or systemic embolism compared with warfarin, regardless of patient age
- PMID: 24935513
- DOI: 10.7326/0003-4819-160-12-201406170-02007
ACP Journal Club. In AF, apixaban reduced stroke or systemic embolism compared with warfarin, regardless of patient age
Comment on
-
Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial.Eur Heart J. 2014 Jul 21;35(28):1864-72. doi: 10.1093/eurheartj/ehu046. Epub 2014 Feb 20. Eur Heart J. 2014. PMID: 24561548 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical